Reflex testing led to substantially fewer provider recommendations for prostate biopsy and MRI
What’s ahead in the Focal Therapy Program at Cleveland Clinic
Study highlights need for mitigation strategies
Technology, big data, advances in prostate cancer
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Meaningful scoring system correlates quality metrics and patient mortality
The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)